Rights and permissions
About this article
Cite this article
Oral topotecan. Inpharma Wkly. 1147, 9 (1998). https://doi.org/10.2165/00128413-199811470-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811470-00015
myelosuppression is the dose-limiting toxicity
4 Accesses
This is a preview of subscription content, log in via an institution to check access.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Rent this article via DeepDyve
Oral topotecan. Inpharma Wkly. 1147, 9 (1998). https://doi.org/10.2165/00128413-199811470-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811470-00015
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative